long COVID – Medxy AI

Digital Biometric Measures in Long COVID: Insights from the STOP-PASC Randomized Clinical Trial Secondary Analysis

By MedXY 09/11/2025

Wearable device data reveal distinct physiological and behavioral patterns reflecting symptom heterogeneity in long COVID, without significant differences between nirmatrelvir-ritonavir and placebo arms.

Clinical Updates Wellness & Lifestyle

Unraveling Mitochondrial Dysfunction as a Key Pathological Feature in Long COVID Syndrome

By MedXY 08/30/2025

Long COVID patients exhibit distinct mitochondrial bioenergetic impairments, with altered ATP synthase function correlating with clinical symptoms and quality of life, implicating mitochondrial dysfunction in its pathogenesis.

Clinical Updates Wellness & Lifestyle

COVID reinfection may raise risk of persistent symptoms by 35%

By MedXY 08/20/2025

Observational data from the RECOVER Initiative suggest that SARS-CoV-2 reinfection raises the risk of long COVID by 35% relative to single infections, with more recent vaccination potentially mitigating this risk.

Medical News Wellness & Lifestyle

Long COVID and the Workforce: Navigating a Complex Path Back to Employment

By MedXY 08/05/2025

Long COVID is keeping millions of workers out of the workforce, with significant barriers to compensation and treatment. Standardized diagnostics, validated therapies, and regulatory reforms are urgently needed to support affected individuals and the healthcare system.

Wellness & Lifestyle

Impact of Obesity on Long COVID: Insights from Primate Studies

By MedXY 07/25/2025

Obesity influences the long-term effects of SARS-CoV-2, revealing diverse outcomes in primates and suggesting broader implications for humans.